PERSPECTA

News from every angle

Back to headlines

EU Approves BioMarin and Amicus Merger

The European Union has given its clearance for the $4.8 billion merger between US pharmaceutical companies BioMarin and Amicus.

7 Apr, 20:14 — 7 Apr, 20:14
PostShare